Document is current
Any future updates will be listed below
-
Authors
Buse, Dawn C.
Pozo-Rosich, Patricia
Dupont-Benjamin, Laure
Balkaran, Bridget L.
Lee, Lulu
Jauregui, Adam
Gandhi, Pranav
Parikh, Mousam
Reuter, Uwe
- License Information
-
More Information
Article History
Received: 25 May 2023
Accepted: 16 August 2023
First Online: 24 August 2023
Declarations
:
: Not applicable.
: DCB has received grant support and honoraria from AbbVie, Amgen, Biohaven, Collegium, Eli Lilly and Company, Lundbeck, and Teva and for work on the editorial board of <i>Current Pain and Headache Reports</i>. PPR, reports personal fees from AbbVie, Amgen, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer, and Teva, and grants paid to her research group from AbbVie, AGAUR, Era-Net Neuron, FEDER RIS3CAT, Instituto Investigación Carlos III, International Headache Society, Novartis, and Teva. UR, reports support for the present study paid to his institution from AbbVie; grants from BMBF (German Ministry for Research) and Novartis; personal and institutional fees from AbbVie, Allergan, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer, StreaMedUp, and Teva. BLB, LL, and AJ are employees of Cerner Enviza and received funding from AbbVie to conduct the study. PG, MP, and LDB are employees of AbbVie and may hold AbbVie stock.
